What’s New

Keeping Asthma Medication within Patients’ Reach

A new bureaucratic obstacle could make it even harder for asthma patients to get the medicine they need. For several years now, high cost-sharing has

Read More

***PRESS RELEASE*** Biosimilars Policy Framework Briefing to Discuss Impact on Prescribing, Reimbursement and Use

Congressional briefing will explore naming, interchangeability, and labeling; reimbursement policies and the Biosimilar User Fee Act  WASHINGTON – On Thursday, April 27 the Biologics Prescribers Collaborative

Read More

Trials Data Raises Hopes in Cystic Fibrosis Community

Promising clinical trials data has excited patients with cystic fibrosis and their families.  But will access barriers dash their hopes for more and better treatment

Read More

***PRESS RELEASE*** New Policy Paper Offers Physician’s Perspective on Oncology Value Models

Institute for Patient Access paper explains value models must serve as tools, not replacements, for physician decision-making  WASHINGTON – The Institute for Patient Access released a

Read More

IfPA Offers the Physician’s Perspective on Oncology Value Models

What is good value in terms of cancer treatment?  The question, amid rising cancer care costs, has prompted a surge of oncology value models in

Read More

***PRESS RELEASE*** South Carolina Health Plans Reject Nearly Half of Claims for High Cholesterol Treatment

New health plan report card analyzes PCSK9 inhibitor claims for managed care organizations  WASHINGTON – The Institute for Patient Access released a new Health Plan

Read More

***PRESS RELEASE*** Ohio Health Plans Reject Nearly Half of Claims for High Cholesterol Treatment

New health plan report card analyzes PCSK9 inhibitor claims for managed care organizations  WASHINGTON – The Institute for Patient Access released a new Health Plan

Read More

Summit on Biologics and Biosimilars Tackles Choice, Switching & Patient Access

Physicians and patients are no longer asking if a biological medicine is the best choice, but – more likely – which biological medicine is the

Read More

***MEDIA ADVISORY*** Thursday Summit on Biologics & Biosimilars Convenes Physicians, Advocates and Officials to Discuss Policy Issues

Summit will explore policies impacting patient access to biologic and biosimilar medications  WASHINGTON – Tomorrow the Institute for Patient Access and Biologics Prescribers Collaborative, a project

Read More

***VIDEO PRESS RELEASE*** AfPA Releases New Video “The Interchangeability Promise”

Video released ahead of 2nd Annual National Policy and Advocacy Summit on Biologics and Biosimilars  WASHINGTON – Today the Alliance for Patient Access released a

Read More
Back to Top